According to Vision Research Reports, the global PCR & real-time PCR molecular diagnostics market size is projected to surpass US$ 6.2 Bn by 2027 with a CAGR of 4.1% from 2020 to 2027.
Polymerase chain reaction (PCR) is used to amplify or make copies of deoxyribonucleic acid (DNA) sequence of interest. It is utilized in various applications including DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. The polymerase chain reaction (PCR) technique is also used in DNA sequencing, cloning, library generations, mutagenesis, and expression profiling. PCR amplifies DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. However, technological advancements and high demand for automate workstations have increased the adoption of real-time PCR and digital PCR techniques in busy, high-throughput laboratories to simplify workflow.
The market growth is primarily driven by factors such as advancements in technology, progress made by quantitative PCR & real-time PCR molecular diagnostics techniques, benefits over other virus isolation and detection techniques, and growing emphasis on improving the reliability of end-results of PCR molecular diagnostics. The demand for PCR & real-time PCR molecular diagnostics has witnessed tremendous growth in 2020, due to the onset of the COVID-19 pandemic. Furthermore, as per current trends, the adoption is likely to gain momentum, as governments around the world continue to take drastic measures to curb the transmission of the COVID-19 virus.
Increase in Demand for Molecular Diagnostic Tools to Propel Global Market
Market Segmentation
In terms of technology, the global PCR & real-time PCR molecular diagnostics market has been classified into traditional PCR, real-time PCR, and digital PCR. The real-time PCR segment accounted for a notable share of the market in 2019. It is projected to maintain is dominance during the forecast period. The segment is expected to be driven by the rise in awareness about PCR based diagnostic techniques and an increase in the demand for real-time-based technologically advanced molecular diagnostics solutions.
In terms of application, the market has been segmented into infectious diseases testing, oncology testing, genetic testing, and others. The infectious disease testing segment has been further categorized into HCV & HBV, sexually transmitted infections, hospital acquired infections, respiratory infections, and others. The infectious disease testing segment is projected to be drive by increase in prevalence of HIV & respiratory infections and rise in the demand for molecular diagnosis for COVID-19.Based on end user, the global PCR & real-time PCR molecular diagnostics market has been divided into hospitals, diagnostic laboratories, academic & research centers, and others. The hospitals segment held a major share of the global market in 2019, owing to increase in focus on providing quality care, rise in emphasis on early diagnostics of diseases, and surge in the number of well-equipped specialty hospitals.
Prominent Regions
North America held a major share of the global PCR & real-time PCR molecular diagnostics market in 2019. Recent product approvals by the Food and Drug Administration (FDA), technological advancements, and expansion of the molecular diagnostic industry are key factors driving the market in the region. Europe followed North America, in terms of share of the global PCR & real-time PCR molecular diagnostics market in 2019. The expansion of the PCR & real-time PCR molecular diagnostics market in the region can be attributed to rapid adoption of latest PCR technology systems, increase in prevalence of infectious diseases, and growing focus on research & development activities. According to an article published by the Swiss Medical Weekly, chronic infection with HCV and HBV are major health concerns in countries across Europe; moreover, due to the prevalence of HCV varies across Europe.
Key Players
Leading players are expanding their footprint to strengthen their position in the global PCR & real-time PCR molecular diagnostics market. Development of innovative PCR technologies for diagnosis of cancer, new product launch, technological advancements, and geographic expansion by prominent market players are likely to offer lucrative opportunities in the global PCR & real-time PCR molecular diagnostics market.
Key players operating in the global PCR & real-time PCR molecular diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd , QIAGEN N.V., Hologic, Inc., GRIFOLS, S.A., Genomic Health, and Seegene, Inc.
Market Segmentation
By Technology
By Product
By Application
By End User
By Region
Scope of the Report
VRR’s report on the global PCR & real-time PCR molecular diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global PCR & real-time PCR molecular diagnostics market for period from 2018 to 2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global PCR & real-time PCR molecular diagnostics market for the same period.
The report has been prepared after extensive research. Primary research involves bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global PCR & real-time PCR molecular diagnostics market.
Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global PCR & real-time PCR molecular diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global PCR & real-time PCR molecular diagnostics market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global PCR & real-time PCR molecular diagnostics market. The next section of the report highlights the USPs, which include regulatory scenario, overview of in-vitro diagnostics market, technological advancement, key industry events (mergers, acquisitions, collaborations, approvals, etc.), and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).
The report delves into the competitive landscape of the global PCR & real-time PCR molecular diagnostics market. Key players operating in the global PCR & real-time PCR molecular diagnostics market have been identified and each one of them has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global PCR & real-time PCR molecular diagnostics market profiled in this report.
Key Questions Answered in PCR & Real-time PCR Molecular Diagnostics Market Report
Research Objectives and Research Approach
The comprehensive report on the global PCR & real-time PCR molecular diagnostics market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global PCR & real-time PCR molecular diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global PCR & real-time PCR molecular diagnostics market, which includes TMR’s analysis of market drivers, restraints, and trends pertaining to the global PCR & real-time PCR molecular diagnostics market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global PCR & real-time PCR molecular diagnostics market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report segments the global PCR & real-time PCR molecular diagnostics market in terms of technology, product, application, end user, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global PCR & real-time PCR molecular diagnostics market.
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers